losartan / Generic mfg. |
ACTRN12617001533381p: Combination low dose blood pressure lowering treatment for patients with untreated hypertension |
|
|
| Not yet recruiting | 4 | 12 | | | George Medicines, George Medicines (The George Institute) | Hypertension | | | | |
ACTRN12617001533381: Combination low dose blood pressure lowering treatment for patients with untreated hypertension |
|
|
| Not yet recruiting | 4 | 12 | | | George Medicines, George Medicines (The George Institute) | Hypertension | | | | |
ACTRN12619000861156p: A comparison of drug metabolism in healthy volunteers and patients with severe chronic obstructive lung disease (COPD) |
|
|
| Not yet recruiting | 4 | 24 | | | Dr Richard McNeill, Canterbury Medical Research Foundation | Chronic obstructive Pulmonary Disease (COPD); Drug metabolism | | | | |
ACTRN12619000861156: A comparison of drug metabolism in healthy volunteers and patients with severe chronic obstructive lung disease (COPD) |
|
|
| Not yet recruiting | 4 | 24 | | | Dr Richard McNeill, Canterbury Medical Research Foundation | Chronic obstructive Pulmonary Disease (COPD), Drug metabolism | | | | |
| Ongoing | 4 | 80 | Europe | Film-coated tablet, Losartan potassium, Perindopril Arginine | Monash Medical Centre , Monash University Health Practitioner Research Fellowship | The pharmacokinetics of oral creatine monohydrate (CrM) dosing in pregnancy, Metabolism of nutraceutical supplement (creatine monohydrate) in pregnancy | | | | |
ChiCTR-TRC-09000462: A randomized, controlled trial to evaluate the safety and efficacy of losartan in obvious proteinuria patients with lower-normal blood pressure |
|
|
| Completed | 4 | 30 | | None ;Losartan 25-50mmHg | Renji Hospital of Shanghai Jiaotong University; Level of the institution:, self-funded | CKD with obvious proteinuria | | | | |
ChiCTR-TRC-09000426: Randomized controlled trial of losartan\propranolol in treating portal hypertension |
|
|
| Completed | 4 | 90 | | Oral losartan by 25mg/d of the initial dose, three days latter alternate to 50mg/d ;Oral propranolol by 20mg/d of initial dose; then, progressively increase 10mg/d, max dose 120mg/d or rest heart rate reduced to the 75% of fundamental rate, or no less than 55/min ;Placebo | Department 1 of Infectious Diseases, 302 Hospital of P.L.A; Level of the institution:, self-finance | portal hypertension | | | | |
ChiCTR-TRC-06000004: ACEi/ARB alone versus ACEi/ARB plus Steroids in the treatment of primary IgA nephropathy, a randomized multicenter controlled trial |
|
|
| Completed | 4 | 156 | | treated with ACEI/ARB( ARB therapy is subjected to patients with cough after use of ACEI) Inhibace (cilazapril): start at 1.25mg/day, increase the dose by 1.25mg/day/week to 2.5-5mg/day Cozaar (losartan): 25~50mg/day, increased to 50~100mg/day Last for one year; Oral prednisone for 6 mos 0.8mg/kg/day x 8 wks Tapered 0.2mg/kg/day/mo in combination with ACEI/ARB | The First Hospital, Peking University; Capital Research Funding for the Development of Medicine, Capital Research Funding for the Development of Medicine | primary IgA nephropathy | | | | |
| Completed | 4 | 600 | | Levamlodipine Besylate ;Losartan | Endocrinology department, The Third Military Medical College, Southwest Hospital Chongqing; Endocrinology department, The Third Military Medical College, Southwest Hospital Chongqing, hospital administration funds | IFG and Hypertension | | | | |
ChiCTR-TRC-11001282: Triptolide Retards Autosomal Dominant Polycystic Kidney Disease with Proteinuria |
|
|
| Completed | 4 | 60 | | Glucosidorum Tripterygll Totorum+losartan potassium ;Placebo + losartan potassium | Shanghai Changzheng Hospital; Science and Technology Commission of Shanghai, Shanghai Key Discipline Project.(No:B902) Shanghai Science and Technology Commission Major Research Project.(No:08dz1900601) | Autosomal dominant polycystic kidney disease | | | | |
ChiCTR-TRC-10000923: Therapeutic effect and safety of Huangkui Capsule for chronic kidney disease: a multi-center, randomized, open label study |
|
|
| Completed | 4 | 420 | | Huangkui Capsule, 2.5g, tid,for 24 weeks ;Losartan, 50mg qd, for 24 weeks ;Huangkui Capsule, 2.5g, tid+ losartan 50mg qd, for 24 weeks | Chinese General Hospital of PLA; SZYY Group Pharmaceutical, SZYY Group Pharmaceutical Limited | chronic kidney disease | | | | |
ChiCTR-TRC-13003612: A Clinical Study of the Efficacy and Safety of Shenyankangfu Tablets in the Treatment of Primary Glomerulonephritis and Diabetic Kidney Disease |
|
|
| Suspended | 4 | 720 | | shenyankangfu tablets + Losartan potassium tablets mimetic agent×2 ;shenyankangfu tablets mimetic agent +losartan potassium tablets 50mg +losartan potassium tablets mimetic agent ;shenyankangfu tablets mimetic agent +losartan potassium tablets 50mg×2 ;shenyankangfu tablets + Losartan potassium tablets 50mg+ losartan potassium tablets mimetic agent ;shenyankangfu tablets +losartan potassium tablets 50mg×2 | Chinese PLA General Hospital; Tianjin TongRenTang Group Co., Ltd., Enterprise Support | Primary Glomerulonephritis and Diabetic Kidney Disease | | | | |
2004-002020-17: ESTRATEGIAS PARA EL TRATAMIENTO DE LA HIPERTENSIÓN ARTERIAL. EVALUACIÓN DE UNA TERAPIA COMBINADA A DOSIS FIJAS (LOSARTÁN/HIDROCLOROTIAZIDA) vs MONOTERAPIA (ESTRATAAR).(STRATEGIES FOR THE TREATMENT OF ARTERIAL HYPERTENSION. ASSESSMENT OF A COMBINED THERAPY AT FIXED DOSES (LOSARTAN/HYDROCHOLOTHIAZIDE) vs MONOTHERAPY (ESTRATAAR) |
|
|
| Ongoing | 4 | 140 | Europe | COZAAR PLUS (losartán / hydrochlorothiazide), COZAAR PLUS, COZAAR PLUS | Catalan Society of Family Medicine, represented by Dr Mariano de la Figuera Von Wichman and Gabriel | Stage II arterial Hypertension | | | | |
2009-010280-17: TS HYPE - Turner syndrome and Hypertension; a double-blinded randomised interventional trial. |
|
|
| Ongoing | 4 | 40 | Europe | Cozaar, Carvedilol PCD, Cozaar, Carvedilol PCD | Organisation name was not entered | Turner syndrome, hypertension and aortopathy | | | | |
2007-006059-37: ENSAYO CLÍNICO PILOTO, ALEATORIZADO, CONTROLADO, PARALELO, DOBLE-CIEGO, PARA EVALUAR LA EFICACIA Y SEGURIDAD DE LOSARTÁN EN LA REDUCCIÓN DEL ESTRÉS OXIDATIVO Y LA DISMINUCIÓN DE LA TENSIÓN ARTERIAL (TA) EN PACIENTES CON SÍNDROME DE WILLIAMS (SW) Y DOS O MÁS COPIAS DEL GEN NCF1. |
|
|
| Ongoing | 4 | 60 | Europe | COZAAR 50 mg comprimidos recubierto con pelicula, COZAAR 50 mg comprimidos recubierto con pelicula | Programa de Medicina Molecular y Genética, Hospital Vall d´Hebron | Pacientes con síndrome de Williams con evidencia molecular de microdeleción en 7q11.2. Edad: Niños de más de 5 años y adultos Sexo: ambos sexos estarán representados lo más paritariemente posible Variante molecular de la deleción que confirme la presencia de 2 o más copias del gen NCF1. | | | | |
2010-024175-58: Comparison of two treatment regimen of high blood pressure in patients with transplanted heart. |
|
|
| Ongoing | 4 | 40 | Europe | perindopril, losartan, furosemid, metoprolol, amlodipin, PRESTARIUM Neo, LORISTA 25, PRESTARIUM Neo Forte, LORISTA 50, LORISTA 100, PRESTARIUM Neo, LORISTA 25, PRESTARIUM Neo Forte, LORISTA 50, LORISTA 100 | IKEM, IKEM | Compensation of arterial hypertension in heart transplant recipients. Renal function and its changes in heart transplant recipients. | | | | |
| Ongoing | 4 | 1 | Europe | Losartan, | | Stiff skin syndrome | | | | |
2014-002524-27: The PALM-study (Placebo, Losartan, Low sodium & Moxonidine after PE) |
|
|
| Ongoing | 4 | 30 | Europe | Losartankalium, Moxonidine, Losartankalium, Moxonidine | University Medical Center Utrecht, ZonMw | Post Partum Hypertension after preeclamptic pregnancy | | | | |
| Ongoing | 4 | 40 | Europe | losartan, N/A, Tablet | University of Oxford, MQ: Transforming Mental Health | DSM panic disorder, Panic disorder is a severe form of anxiety that is characterised by the occurence of intense panic attacks, without an apparent external reason., Psychiatry and Psychology [F] - Psychological processes [F02] | | | | |
ChiCTR-IPR-16008108: Songling Xuemaikang Capsule for primary hypertension with the control of Losartan potassium: a multi-center, randomized, double-blind controlled trial |
|
|
| Recruiting | 4 | 640 | | Songling Xuemaikang capsule,the placebo of Losartan Potassium ;Losartan Potassium, the placebo of Songling Xuemaikang capsule | Dongzhimen hospital affiliated of Beijing University of Chinese Medicine; Shanghai Changzheng hospital; Dongzhimen hospital affiliated of Beijing University of Chinese Medicine, Pharmaceutical Co., Ltd. Chengdu Nakasone | Primary hypertension | | | | |
ChiCTR-IPR-16009366: Clinical trial for evaluation of the breviscapine affect to cytochrome P450 enzymes and transporter in healthy volunteers |
|
|
| Recruiting | 4 | 18 | | 40mg po tid of placebo for two week, on the 15th day a single dose of fexofenadine120mg or midazolam 7.5mg or losartan potassium 50mg is given to volunteers ;40mg po tid of breviscapine for two week, on the 15th day a single dose of fexofenadine120mg or midazolam 7.5mg or losartan potassium 50mg is given to volunteers | College of Pharmacy and Chemistry, Dali University; College of Pharmacy and Chemistry, Dali University, Nation Natural Science Foundation of China | Healthy | | | | |
NCT05827484: The Effect of Combined Use of Anti-fibrotic Agent With Platelet Rich Plasma on Skeletal Muscle Healing After Acute Injuries |
|
|
| Completed | 4 | 20 | NA | Autologous platelets rich plasma, PRP, Autologous platelets rich plasma + oral LOSARTAN administration, PRP + LOSARTAN | Mostafa Hassanein, Msc | PRP, Losartan, Muscle Injury, Sport Injury | 09/17 | 12/17 | | |
ChiCTR-IIR-17013487: A multicenter, double blind, double dummy, randomized controlled clinical study on the treatment of IgA nephropathy with Zhengqingfengtongning extantab |
|
|
| Recruiting | 4 | 108 | | Zhengqing Fengtongning extantab ;Losartan Potassium Tablets ;Losartan Potassium Tablets + Zhengqing Fengtongning extantab | The Third Xiangya Hospital of Central South University; The Third Xiangya Hospital of Central South University, Major projects of Hunan provincial science and Technology Department、Hunan Zhengqing Pharmaceutical Group Co., Ltd. | IgA nephropathy | | | | |
2020-001595-15: Measures to slow the progression of chronic kidney disease in patients with protein in the urine and elevated potassium in the blood Et videnskabeligt forsøg med personer med kronisk nyresvigt og protein i urinen |
|
|
| Not yet recruiting | 4 | 140 | Europe | Spironolactone, Losartan, Tablet, Oral powder in sachet, Coated tablet, Veltassa | Henrik Birn, Vifor Fresenius Medical Care Renal Pharma AG, Graduate School of Health Sciences, Aarhus University | Chronic kidney disease with albuminuria Kronisk nyresygdom med albuminuri, Chronic kidney disease with protein in the urine Kronisk nyresygdom med æggehvidestof i urinen, Not possible to specify | | | | |
2019-003141-15: Renohemodynamic Effects of Combined empagliflOzin and LosARtan |
|
|
| Not yet recruiting | 4 | 24 | Europe | Empagliflozine, Losartan, Film-coated tablet, Jardiance, Cozaar | Amsterdam University Medical Center - location VU Medical Center, Boehringer Ingelheim | Diabetes Mellitus type 2, Diabetes, Diseases [C] - Hormonal diseases [C19] | | | | |
ChiCTR1900021113: Diabetic Kidney Disease with Qi and Yin Deficiency, Blood Stasis Syndrome Treated by Keluoxin Capsule Combined with Losartan Potassium: a randomized, double blinding, placebo controlled, multicenter clinical study |
|
|
| Not yet recruiting | 4 | 252 | | Keluoxin Capsule+Losartan Potassium ;Placebo of Keluoxin Capsule + Losartan Potassium | Guang'anmen Hospital, Chinese Academy of Chinese Medical Sciences; Guang'anmen Hospital, Chinese Academy of Chinese Medical Sciences, Self-raising | Diabetic Kidney Disease | | | | |
ChiCTR1900023531: Efficacy and safety of Astragalus plus Notoginseng granule on type 2 diabetic nephropathy: the multi-centre randomized controlled trial |
|
|
| Not yet recruiting | 4 | 100 | | losartan ;Astragalus plus Notoginseng granule combined losartan | Shanghai Sixth People's Hospital East; Shanghai Sixth People's Hospital East Campus, Shanghai municipal health and family planning commission | diabetic nephrology | | | | |
NCT06718062: Non-Inferiority Study of Aliskiren vs Losartan in the Treatment of Hypertension With Hyperuricemia |
|
|
| Completed | 4 | 66 | RoW | Aliskiren, Losartan | Hansung University | Hypertension,Essential, Hyperuricemia | 05/24 | 10/24 | | |
ChiCTR2000039934: The role of oral losartan in the prevention of acute mountain sickness: a randomized controlled trial |
|
|
| Not yet recruiting | 4 | 200 | | oral Roxadustat capsules 50mg, BIW ;Oral placebo capsules,the same dosage as Oral Roxadustat | Western Theater Air Force Hospital; Western Theater Air Force Hospital, Western Theater Air Force Hospital | Acute altitude illness | | | | |
2021-001661-21: Feasibility of aggressively lowering urine albumin in individuals with kidney biopsy-proven diabetic kidney disease - A Pilot Study |
|
|
| Not yet recruiting | 4 | 20 | Europe | Tablet, Injection, Forxiga, Jardiance, Ozempic, Telmisartan, Losartan, hydrochlorthiazide, Spironolactone, Trental, Olumiant, Kerendia, Rybelsus | Herlev and Gentofte Hospital, Herlev and Gentofte Hospital | Diabetic Kidney Disease, Kidney Disease due to diabetes mellitus type 2, Diseases [C] - Hormonal diseases [C19] | | | | |
| Recruiting | 4 | 50 | US | Sacubitril-Valsartan, Entresto, Usual care (standard-of-care) arm, Oral Vasodilator | The Cleveland Clinic | Stage D Heart Failure | 03/22 | 12/22 | | |
ChiCTR2000036108: Study on the safety and feasibility of losartan targeted therapy for pulmonary vein stenosis |
|
|
| Not yet recruiting | 4 | 160 | | oral losartan ;Not taking losartan | Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine; Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai Shen Kang Hospital Development Center | Acquired pulmonary venous obstruction | | | | |
MRA-ACE, NCT03502031: Safety and Efficacy of Two Year of RAAS Alone or in Combination With Spironolactone Therapy |
|
|
| Recruiting | 4 | 72 | US | Renin-Angiotensin (RAAS) alone, Lispril, Enalapril, Perindopril, Losarta, Valsar etc.,, Renin-Angiotensin (RAAS) blockers in combination with Spironolactone, Lisinopril, Enalapril, Perindopril, Losartan, Valsartan, or Spironolactone | James A. Tumlin, MD, Nelson Kopyt, MD | Renal Insufficiency, Chronic, Diabetic Nephropathy Type 2 | 10/22 | 10/24 | | |
ChiCTR2000040391: Efficacy, safety and weight loss mechanism of pegylated losartan in obese patients with type 2 diabetes mellitus |
|
|
| Not yet recruiting | 4 | 150 | | placebo ;Losenatide 100ug ;Losenatide 200ug ;Losenatide 300ug ;orlistat | The Second XIANGYA Hospital Of Central South University; The Second XIANGYA Hospital Of Central South University, Supported by China International Medical Exchange Foundation, Sumei China Diabetes Research Foundation in 2020 | obese patients with type 2 diabetes mellitus | | | | |
NCT06431477: Efficacy and Safety of Telmisartan Compared With Losartan |
|
|
| Recruiting | 4 | 98 | RoW | telmisartan, Losartan | Chong Kun Dang Pharmaceutical | Diabetic Nephropathies, Hypertension | 10/25 | 10/25 | | |
NCT03692013: Nighttime Losartan in Continous Ambulatory Peritoneal Dialysis (NVCAPD) |
|
|
| Not yet recruiting | 4 | 68 | NA | Losartan, Cozaar | Fifth Affiliated Hospital, Sun Yat-Sen University, Third Affiliated Hospital, Sun Yat-Sen University | Hypertension,Nephropathy | 06/23 | 12/23 | | |
ChiCTR2000035247: Clinical study of oral losartan application for the treatment of knee osteoarthritis: a randomized controlled trial. |
|
|
| Not yet recruiting | 4 | 98 | | Oral losartan 50mg/ for 2 years ;Oral placebo 50mg/ for 2 years | Shenzhen Second People's Hospital; Shenzhen Second People's Hospital, Clinical Research Project of Shenzhen Second People's Hospital | osteoarthritis | | | | |
| Active, not recruiting | 4 | 2476 | US | High dose potent statin, atorvastatin or rosuvastatin, ACE-I (lisinopril) or ARB (losartan), ACE-I or ARB, Aspirin, Lifestyle Counseling, PACE Lifestyle Intervention, Quality of Life Questionnaires, QOL | University of Florida, United States Department of Defense | Coronary Artery Disease | 02/25 | 09/25 | | |
ChiCTR2000029417: Astragali Radix and Panax notoginseng combination for the treatment of diabetic nephropathy: clinical randomized controlled trial and mechanism study |
|
|
| Recruiting | 4 | 106 | | Placebo combined with losartan ;Astragalus plus Notoginseng granule combined losartan | Shanghai Sixth People's Hospital; Shanghai Sixth People's Hospital, National Key R&D Program of China | diabetic nephrology | | | | |
NCT05402397: Losartan and Uric Acid Metabolism in Children With Proteinuric Nephropathies |
|
|
| Recruiting | 4 | 40 | RoW | Losartan Potassium | Hospital General de Niños Pedro de Elizalde | Uric Acid Nephropathy | 12/23 | 07/24 | | |
PRISTINE, NCT05843162: A Clinical Trial to Evaluate the Blood Pressure Control of Telmisartan or Losartan in Essential Hypertensive Patients With Metabolic Syndrome |
|
|
| Not yet recruiting | 4 | 116 | NA | Telmisartan, Losartan | Chong Kun Dang Pharmaceutical | Essential Hypertension, Metabolic Syndrome | 12/23 | 12/23 | | |
| Recruiting | 4 | 878 | Europe | Corticosteroid, Methylprednisolone succinate, prednisolone, Renin-angiotensin sytem blockers, Ramipril, lisinopril, losartan, Sodium-glucose cotransporter 2 inhibitor, dapagliflozin, canagliflozin, empagliflozin | Fondazione Schena, University of Bari | Glomerulonephritis, Immunoglobulin A Nephropathy | 06/24 | 12/26 | | |
NCT06333522: Losartan Use to Mitigate Arthrofibrosis Following Total Joint Arthroplasty |
|
|
| Withdrawn | 4 | 240 | US | Losartan | NYU Langone Health | Arthrofibrosis of Knee | 01/26 | 01/26 | | |
NCT05157464: Losartan Use to Mitigate Arthrofibrosis Following Total Join Arthroplasty |
|
|
| Withdrawn | 4 | 380 | US | Losartan | NYU Langone Health | Arthrofibrosis | 12/24 | 12/24 | | |
ChiCTR2300078226: Efficacy and safety of initial treatment of Finerenone combined with Henagliflozein in patients with type 2 diabetes with microalbuminuria: a randomized, parallel, controlled, three-arm clinical study |
|
|
| Recruiting | 4 | 300 | | Losartan 50mg qd combined with Henagliflozein 5mg qd; Losartan 50mg qd combined with Finerenone 10mg qd; Losartan 50mg qd in combination with Finerenone 10mg qd and Henagliflozein 5mg qd | Peking University First Hospital; Peking University First Hospital, self-funded | Type 2 diabetes | | | | |
NCT02817360: NT-proBNP Selected Prevention of Cardiac Events in Diabetic Patients |
|
|
| Recruiting | 4 | 2400 | Europe, RoW | RAS-antagonist and beta-blocker up-to maximal dosages, Enalapril 40mg/d, Ramipril 10mg/d, Lisinopril 40mg/d, Cilazapril 5mg/d, Perindopril 8mg/d, Captopril 150mg/d, Spirapril 24mg/d, Quinapril 40mg/d, Trandolapril 4mg/d, Zofenopril 60mg/d, Fosinopril 40mg/d, Candesartan 32mg/d, Valsartan 320mg/d, Irbesartan 300mg/d, Losartan 150mg/d, Eprosartan 800mg/d, Bisoprolol 10mg/d, Metoprololsuccinat 200mg/d, Carvedilol 50mg/d (100mg/d if weight is > 85kg), Nebivolol 10mg/d, RAS-antagonist and beta-blocker none or at stable dose | Martin Huelsmann | Heart Diseases, Diabetes Mellitus, Type 2 | 12/25 | 12/26 | | |
NCT04715568: Secondhand Tobacco Smoke and Cardiovascular Disease |
|
|
| Recruiting | 4 | 100 | US | Losartan, Cozaar, Angiotensin II Receptor Blocker, Antihypertensive, Placebo, Inactive drug | University of California, San Francisco, Flight Attendant Medical Research Institute | Cardiovascular Diseases, Hypertension | 12/25 | 12/25 | | |
2013-002091-41: Research into the effect of the drug losartan in adult patients with a reduced function of the right cardiac chamber and a cardiac birth defect Onderzoek naar de werking van het medicijn losartan bij volwassen patienten met een verminderde functie van de rechter hartkamer en een aangeboren hartafwijking |
|
|
| Ongoing | 3/4 | 120 | Europe | Losartan, Capsule, hard, Losartan | Academisch medisch centrum, ICIN | To study the effect of losartan in adult patients with Tetralogy of Fallot and right ventricular dysfunction, defined as right ventricular ejection fraction <50%. Without severe valvular lesions., Research into the effect of the drug losartan in patients with tetralogy of Fallot and decreased right heart chamber function, Diseases [C] - Cardiovascular Diseases [C14] | | | | |
2015-000239-34: A clinical study to investigate the use of commonly used heart failure medicines in the prevention of heart related illnesses in patients with diabetes mellitus but without heart disease. |
|
|
| Ongoing | 3/4 | 2400 | Europe, RoW | Enalapril maleate, Ramipril, Lisinopril dihydrate, Perindopril arginine, Perindopril erbumine, Perindopril tert-butylamine, Captopril, Quinapril hydrochloride, Trandolapril, Fosinopril sodium, Candesartan cilextil, Valsartan, Irbesartan, Losartan potassium, Eprosartan mesilate, Bisoprolol fumerate, Carvedilol, Nebivilol hydrochloride, Not applicable, Tablet, , Capsule | Medizinische Universität Wien, Medical University of Vienna, Medizinische Universität Wien, | Type 2 diabetes mellitus, Type 2 diabetes, Diseases [C] - Hormonal diseases [C19] | | | | |
2005-004545-34: Can Angiotensin II type 1 Receptor Inhibitor Be Used to Lower the Amount of Lipase and Amylase Level after Endoscopic Retrograde Cholangio-Pancreatography? |
|
|
| Ongoing | 3 | 400 | Europe | Cozaar, Cozaar | Unit of Esophageal and Gastric Research Dep. of Molecular Medicine and Surgery Karolinska Institutet | The clinical diagnosis of acute pancreatitis is set by a combination of symptoms (abdominal pain) and increased blood levels of pancreatic enzymes (i.e. amylase and lipase). The most common complication of Endoscopic Retrograde Cholangio-Pancreatography (ERCP) is acute pancreatitis (7%, Freeman et al 1996). Increased blood levels of amylase and lipase is seen in 25-40% of cases after ERCP (Tsujino et al 2005). | | | | |
ACTRN12615001322527: Effect of angiotensin receptor blockers on blood pressure control among euvolemic hypertensive hemodialysis patients: a randomized controlled trial |
|
|
| Active, not recruiting | 3 | 88 | | | Universiti Sains Malaysia, Universit Sains Malaysia | hypertension in End stage renal disease | | | | |
ChiCTR1800016427: A randomized, double-blind, double-simulation controlled trial of Sang-qi Granula on treating of vascular endothelial function of primary hypertension |
|
|
| Not yet recruiting | 3 | 300 | | Traditional Chinese medicine group will be given San-qi Granula and Cozaar placebo for 2 months, Sang-Qi granule will be taken every morning and evening, 10g every time, and the Cozaar placebo will be taken 50mg every morning. ;Western medicine group will be given Cozaar and San-qi Granula placebo for 2 months, and Cozaar will be taken 50mg every morning, Sang-Qi granule placebo will be taken every morning and evening, 10g every time. ;Traditional Chinese medicine+ Western medicine group will be given San-qi Granula and Cozaar for 2 months, Sang-Qi granule will be taken every morning and evening, 10g every time, and the Cozaar will be taken 50mg every morning. | China-Japanese Friendship Hospital; China-Japanese Friendship Hospital, Funding for scientific research on capital health development in 2018, The State Administration of traditional Chinese medicine | primary hypertension | | | | |
ARBs CORONA II, NCT04606563: Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan and Other ARBs on Outcomes of Coronavirus Infection? |
|
|
| Terminated | 3 | 341 | Europe, Canada | Losartan, Cozaar, Valsartan, Diovan, Azilsartan, Edarbi, Candesartan, Atacand, Eprosartan, Teventen, Irbesartan, Avapro, Olmesartan, Olmetec, Telmisartan, Micardis | University of British Columbia, Canadian Institutes of Health Research (CIHR) | Covid19, SARS-CoV Infection | 04/22 | 04/22 | | |
| Terminated | 3 | 101 | Europe | Amlodipine, Losartan, Atenolol | Ludwig-Maximilians - University of Munich, University of Edinburgh, Maastricht University Medical Center, UMC Utrecht, University of Oxford | Cerebral Small Vessel Diseases | 07/22 | 07/22 | | |
ChiCTR1800014345: The preventive effect of improving high filtration in subclinical stage on diabetic nephropathy: a prospective, multicenter cohort study |
|
|
| Recruiting | 3 | 120 | | dapagliflozin ;Losartan ;Empagliflozin | Tianjin Metabolic Diseases Hospital & Tianjin Medical University; Tianjin Medical University Metabolic Diseases Hospital, Tianjin Medical University | diabetic nephropathy | | | | |
2022-001682-12: A study to assess the efficacy of a cardiac drug and a anti-inflammatory drug in patients with post-acute inflammatory heart disease due to COVID-19 |
|
|
| Not yet recruiting | 3 | 280 | Europe | Losartan-Kalium, Prednisolon 10 mg, Prednisolon, Capsule, hard, Losartan-Kalium TAD® 12,5 mg Filmtabletten, Losartan-Kalium TAD® 25 mg Filmtabletten, Prednisolon 10 mg JENAPHARM®, Prednisolon 5 mg JENAPHARM® | Goethe University Frankfurt, Bayer AG | Inflammatory cardiovascular involvement due to COVID-19, defined by Cardiovascular magnetic resonance imaging, COVID-19 disease with cardiovascular inflammatory involvement, Diseases [C] - Virus Diseases [C02] | | | | |
| Active, not recruiting | 3 | 1155 | Canada, RoW | Angiotensin converting enzyme inhibitor, Angiotensin II Receptor Blockers | Ottawa Heart Institute Research Corporation | COVID-19, Cardiovascular Diseases | 12/24 | 12/25 | | |
VALUE, NCT06150560: A Study of Angiotensin-II Receptor Blocker on Cardiovascular Remodeling ( Trial) |
|
|
| Recruiting | 3 | 120 | US | Losartan, Cozaar, Amlodipine, Placebo | Mayo Clinic, National Heart, Lung, and Blood Institute (NHLBI) | Coarctation of Aorta, High Blood Pressure | 06/28 | 06/28 | | |
| Recruiting | 3 | 280 | Europe | Prednisolone, Losartan | Valentina Puentmann, Bayer, Alcedis GmbH | COVID-19 Associated Cardiac Involvement, Remodeling, Left Ventricle, Remodeling, Vascular, Left Ventricular Dysfunction, Exercise Intolerance, Vascular Inflammation, Microvascular Angina | 12/24 | 12/28 | | |
| Recruiting | 3 | 20000 | Europe, Canada, Japan, US, RoW | Ceftriaxone, Moxifloxacin or Levofloxacin, Piperacillin-tazobactam, Ceftaroline, Amoxicillin-clavulanate, Standard course macrolide, Extended course macrolide, No systemic corticosteroid, Fixed-duration Hydrocortisone, Shock-dependent hydrocortisone, Fixed-duration higher dose Hydrocortisone, No antiviral agent for influenza, Five-days oseltamivir, Ten-days oseltamivir, No antiviral agent for COVID-19, Lopinavir / Ritonavir, Hydroxychloroquine, Hydroxychloroquine + lopinavir/ritonavir, Ivermectin, No immune modulation for COVID-19, Interferon beta-1a, IFN-β1a, Anakinra, Tocilizumab, Sarilumab, Local standard venous thromboprophylaxis, Therapeutic dose anticoagulation, Conventional low dose thromboprophylaxis, Intermediate dose thromboprophylaxis, Continuation of therapeutic dose anticoagulation, No immunoglobulin, Convalescent plasma, Delayed administration of convalescent plasma, No vitamin C, Vitamin C, No antiplatelet, Aspirin, acetylsalicylic acid, P2Y12 inhibitor, Clopidogrel, Prasugrel, Ticagrelor, No simvastatin, Simvastatin, Eritoran, Apremilast, Clinician-preferred mechanical ventilation strategy, Protocolised mechanical ventilation strategy, No renin-angiotensin system inhibitor, Angiotensin converting enzyme inhibitor, Ramipril, Lisinopril, Perindopril, Enalapril, Trandolapril, Captopril, Angiotensin Receptor Blockers, Losartan, Valsartan, Candesartan, Irbesartan, Telmisartan, Olmesartan, ARB + DMX-200, No cysteamine, Cysteamine, Fixed-duration dexamethasone, Baloxavir Marboxil, Five-days oseltamivir + baloxavir marboxil, Ten-days oseltamivir + baloxavir marboxil, No endothelial modulator, Imatinib, No Immune Modulator for Influenza, Baricitinib, Nirmatrelvir/ritonavir, Paxlovid, Remdesivir, Nirmatrelvir/ritonavir + remdesivir | UMC Utrecht, Australian and New Zealand Intensive Care Research Centre, Medical Research Institute of New Zealand, Unity Health, Berry Consultants, Global Coalition for Adaptive Research, University of Pittsburgh Medical Center, Intensive Care National Audit & Research Centre, St. Marianna University School of Medicine, Nat Intensive Care Surveillance - MORU, National University Hospital, Singapore | Community-acquired Pneumonia, Influenza, COVID-19 | 02/26 | 02/28 | | |
NCT00720044: Effect of Losartan on Chronic Obstructive Pulmonary Disease (COPD) |
|
|
| Recruiting | 2/3 | 120 | US | Losartan, Cozaar, Placebo, "sugar pill" | National Heart, Lung, and Blood Institute (NHLBI) | COPD, Emphysema, Chronic Obstructive Pulmonary Disease, Chronic Bronchitis | 06/12 | 09/12 | | |
| Completed | 2 | 288 | | Allisartan 80mg, orally taken once daily for 8 weeks ;Allisartan 160mg, orally taken once daily for 8 week ;Allisartan 240mg, orally taken once daily for 8 weeks ;losartan 50mg, orally taken once daily for 8 weeks | Peking University People's Hospital; Shanghai Allist Pharmaceuticals, Shanghai Allist Pharmaceuticals, Inc. | Mild to moderate essential hypertension | | | | |
2010-022073-34: Effetto antipertensivo di differenti dosi del Rostafuroxin inconfronto con Losartan, valutato con Rilevazioni Pressorie Ambulatoriali eMonitoraggio Pressorio nelle 24 ore in pazienti ipertesi portatori di unospecifico profilo genetico. Effetto antipertensivo di differenti dosi del Rostafuroxin inconfronto con Losartan, valutato con Rilevazioni Pressorie Ambulatoriali eMonitoraggio Pressorio nelle 24 ore in pazienti ipertesi portatori di unospecifico profilo genetico. |
|
|
| Not yet recruiting | 2 | 280 | Europe | Rostafuroxin, Losaprex 50 mg, PST2238, Losartan 50 mg, Capsule, hard, Tablet, Losaprex 50 mg cpr riv | CVIE THERAPEUTICS COMPANY LIMITED, Cvie Therapeutics Company Limited | Patients with arterial hypertension, bearers of a specific genetic profile (Presence of at least one mutated genotype or combination of genotypes corresponding to the list provided in Genetic Profile 1). Pazienti Italiani e Cinesi, con ipertensione arteriosa, mai trattati prima, portatori di un profilo genetico specifico, Hypertension Ipertensione, Diseases [C] - Cardiovascular Diseases [C14] | | | | |
2009-016139-36: The AT1 receptor antagonist losartan for the prevention of excessive aortic root dilatation in children and adolescents with Marfan syndrom |
|
|
| Ongoing | 2 | 25 | Europe | Losartan, LOSARTAN \"Hexal\" 50 mg - Filmtabletten, LOSARTAN \"Hexal\" 50 mg - Filmtabletten | Medizinische Universität Wien, Univ.Klinik für Kinder-und Jugendheilkunde | Marfan-Syndrom | | | | |
2010-018880-41: EFFECTS OF LOSARTAN ON AORTIC ROOT AND ASCENDING AORTA REMODELING IN PATIENTS WITH BICUSPID AORTIC VALVE. |
|
|
| Ongoing | 2 | 40 | Europe | LORTAAN, LORTAAN | AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI | PATIENTS WITH BICUSPID AORTIC VALVE. | | | | |
2018-004653-24: Importance of ARB medication in preventing valvular heart disease Betydning af angiotensin receptor blocker behandling hos patienter med hovedpulsreklap forsnvring |
|
|
| Not yet recruiting | 2 | 280 | Europe | losartan, C09CA01, Tablet, losartan | Odense Universitets Hospital, Odense Universitetshospital | Aortic valve stenosis Aortastenose, Aortic valve narrowing Hovedpulsåreklapforsnævring, Diseases [C] - Cardiovascular Diseases [C14] | | | | |
ACTRN12619001078145: Novel treatment of patients with Advanced Cancers using a combination of commonly available, low cost oral medications.
|
|
|
| Terminated | 2 | 50 | | | Gillies McIndoe Research Institute, Gillies McIndoe Research Institute | Glioblastoma,, Metastatic Melanoma, Oral cavity Squamous cell carcinoma, Head and Neck skin Squamous cell carcinoma | | | | |
NCT03563248: Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer |
|
|
| Active, not recruiting | 2 | 168 | US | FOLFIRINOX, Losartan, Nivolumab, SBRT, Surgery | Massachusetts General Hospital, Bristol-Myers Squibb, Stand Up To Cancer, Lustgarten Foundation | Pancreatic Cancer | 07/22 | 06/27 | | |
| Terminated | 2 | 78 | Europe | Losartan 50 mg and Spironolactone 25 mg pillules oral use | Assistance Publique Hopitaux De Marseille | COVID-19, ARDS | 12/21 | 12/21 | | |
2022-001939-88: Clinical study on the combination of Losartan (antihypertensive drug) and chemotherapy followed by stereotactic radiotherapy, a non-invasive radiotherapy technique, for the treatment of locally advanced pancreatic cancer Studio clinico sulla combinazione di Losartan (farmaco antipertensivo) e chemioterapia seguito da radioterapia stereotassica, tecnica radioterapica non invasiva, per il trattamento del Tumore del Pancreas Localmente Avanzato |
|
|
| Not yet recruiting | 2 | 34 | Europe | Losartan DOC 12,5 mg, LORTAAN, [Losartan DOC 12, 5 mg], [LORTAAN], Film-coated tablet, LOSARTAN DOC GENERICI - 12.5 MG COMPRESSE RIVESTITE CON FILM 21 COMPRESSE IN BLISTER PVC/PVDC/PELLICOLA DI ALLUMINIO, LORTAAN - 50 MG COMPRESSE RIVESTITE CON FILM 28 COMPRESSE | ISTITUTO SCIENTIFICO ROMAGNOLO PER LO STUDIO E LA CURA DEI TUMORI (IRST) S.R.L. IRCCS | Unresectable locally advanced, non-metastatic pancreatic cancer (as described by NCCN guidelines version 1.2022) Tumore del pancreas localmente avanzato non resecabile (come da linee guida NCCN versione 1.2022), Locally advanced non-metastatic and non-operable pancreatic cancer Tumore del pancreas localmente avanzato non metastatico e non operabile, Diseases [C] - Cancer [C04] | | | | |
NCT03632213: Evaluation of Losartan on Cardiovascular Disease in Patients With Mucopolysaccharidoses IV A and VI |
|
|
| Active, not recruiting | 2 | 10 | RoW | Losartan, Placebo | Hospital de Clinicas de Porto Alegre, The Isaac Foundation | Mucopolysaccharidosis IV A, Mucopolysaccharidosis VI, Mucopolysaccharidoses, MPS IV A, MPS VI, MPS - Mucopolysaccharidosis, Morquio A Syndrome, Morquio Syndrome A, Morquio Syndrome | 05/23 | 08/23 | | |
| Recruiting | 2 | 100 | RoW | Sacubitril-valsartan, Entresto, Amlodipine-losartan, Amosartan | Samsung Medical Center | Aortic Valve Insufficiency | 12/23 | 12/24 | | |
NCT06135493: Prevention of Paclitaxel-induced Peripheral Neuropathy in Breast Cancer Patients |
|
|
| Recruiting | 2 | 84 | RoW | Losartan | Future University in Egypt | Peripheral Neuropathy Due to Chemotherapy | 03/25 | 03/25 | | |
NCT05012631: Losartan for Diffuse Myocardial Fibrosis in Sickle Cell Disease |
|
|
| Recruiting | 2 | 24 | US | Losartan | Children's Hospital Medical Center, Cincinnati | Sickle Cell Disease, Diffuse Myocardial Fibrosis | 12/25 | 12/26 | | |
NCT05077800: FOLFIRINOX + 9-Ing-41 + Losartan In Pancreatic Cancer |
|
|
| Recruiting | 2 | 70 | US | FOLFIRNINOX, Losartan, Cozaar, 9-ING-41 | Colin D. Weekes, M.D., PhD, Actuate Therapeutics Inc., Lustgarten Foundation | Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma Metastatic | 12/25 | 07/26 | | |
NeoOPTIMIZE, NCT04539808: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer |
|
|
| Active, not recruiting | 2 | 60 | US | Capecitabine, Ro 09-1978/000, Xeloda, Fluorouracil, 5 Fluorouracil, 5 Fluorouracilum, 5 FU, 5-Fluoro-2,4(1H, 3H)-pyrimidinedione, 5-Fluorouracil, 5-Fluracil, 5-Fu, 5FU, AccuSite, Carac, Fluoro Uracil, Fluouracil, Flurablastin, Fluracedyl, Fluracil, Fluril, Fluroblastin, Ribofluor, Ro 2-9757, Ro-2-9757, Irinotecan Hydrochloride, Campto, Camptosar, Camptothecin 11, Camptothecin-11, CPT 11, CPT-11, Irinomedac, Irinotecan Hydrochloride Trihydrate, Irinotecan Monohydrochloride Trihydrate, U-101440E, Leucovorin Calcium, Adinepar, Calcifolin, Calcium (6S)-Folinate, Calcium Folinate, Calcium Leucovorin, Calfolex, Calinat, Cehafolin, Citofolin, Citrec, Citrovorum Factor, Cromatonbic Folinico, Dalisol, Disintox, Divical, Ecofol, Emovis, Factor, Citrovorum, Flynoken A, Folaren, Folaxin, FOLI-cell, Foliben, Folidan, Folidar, Folinac, Folinate Calcium, folinic acid, Folinic Acid Calcium Salt Pentahydrate, Folinoral, Folinvit, Foliplus, Folix, Imo, Lederfolat, Lederfolin, Leucosar, leucovorin, Rescufolin, Rescuvolin, Tonofolin, Wellcovorin, Losartan Potassium, Cozaar, losartan, Oxaliplatin, 1-OHP, Ai Heng, Aiheng, Dacotin, Dacplat, Diaminocyclohexane Oxalatoplatinum, Eloxatin, Eloxatine, JM-83, Oxalatoplatin, Oxalatoplatinum, RP 54780, RP-54780, SR-96669, Radiation Therapy, Cancer Radiotherapy, ENERGY_TYPE, Irradiate, Irradiated, Irradiation, Radiation, Radiation Therapy, NOS, Radiotherapeutics, Radiotherapy, RT, Therapy, Radiation, Resection, Surgical Resection, Diagnostic Imaging, Medical Imaging, Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection | OHSU Knight Cancer Institute, Oregon Health and Science University | Pancreatic Adenocarcinoma, Stage 0 Pancreatic Cancer AJCC v8, Stage I Pancreatic Cancer AJCC v8, Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8 | 04/25 | 10/25 | | |
HIPAC, NCT03354143: Hypertension, Intracranial Pulsatility and Brain Amyloid-beta Accumulation in Older Adults ( Trial) |
|
|
| Completed | 2 | 85 | US | Standard Care, Intensive Treatment | University of Texas Southwestern Medical Center, Texas Health Resources, Michigan State University | Hypertension | 01/24 | 03/24 | | |
| Completed | 2 | 223 | US | Aerobic exercise, Perindopril, Losartan, HCTZ | University of Alabama at Birmingham, University of Colorado, Denver, AdventHealth Translational Research Institute | Hypertension, Aging, Sedentary Lifestyle | 09/24 | 09/24 | | |
NCT05871333: Effect of Losartan on the Incidence and Severity of Chemotherapy-Induced Mucositis in Gastrointestinal Cancer Patients |
|
|
| Recruiting | 2 | 80 | RoW | Losartan 50mg Tab, Angiotension receptor blockers | Ain Shams University | Chemotherapy, Colorectal Cancer, Intestinal Mucositis, Oral Mucositis | 06/24 | 07/24 | | |
NCT06364176: Targeting Inflammation With Losartan to Improve Response to Modulator Therapy in Cystic Fibrosis. |
|
|
| Recruiting | 2 | 42 | US | Losartan, Placebo | University of Kansas Medical Center | Cystic Fibrosis | 05/27 | 10/27 | | |
ChiCTR2200064190: Exploring the Optimal Diagnosis and Treatment Strategy of Traditional Chinese Medicine Preparation Sangqi Qingxuan Ointment For Prevention and Treatment of Prehypertension and Grade 1 Hypertension: Based on the Regulation of Autonomic Nerve Function |
|
|
| Not yet recruiting | 2 | 180 | | Sangqi Qingxuan Ointment ;Losartan Potassium | China-Japan Friendship Hospital; China-Japan Friendship Hospital, China-Japan Friendship Hospital | hypertension | | | | |
| Enrolling by invitation | 2 | 165 | Europe | Losartan | Kyrre Eeg Emblem | Glioblastoma, Brain Metastases | 10/24 | 12/24 | | |
WHUH-BC-001, NCT05097248: Camrelizumab in Combination With PLD and Losartan in Patients With TNBC Who Have Received ≦ 1 Line of Chemotherapy |
|
|
| Not yet recruiting | 2 | 52 | RoW | Camrelizumab, Liposomal Doxorubicin, Losartan | Wuhan Union Hospital, China, Jiangsu HengRui Medicine Co., Ltd., CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Breast Cancer | 10/24 | 10/24 | | |
| Recruiting | 2 | 120 | US | Anti-hypertensive agent: amlodipine, Anti-hypertensive agent: Chlorthalidone, Anti-hypertensive agent: Losartan, Home BP monitoring with cuffed device, Home BP monitoring with cuffed device + BP patch, Home BP monitoring with cuffed device + BP watch | University of California, San Francisco | Hypertension | 05/25 | 05/27 | | |
ChiCTR2400082666: A single-arm, multicenter prospective study of RAS inhibitors combined with bevacizumab in patients with mCRC |
|
|
| Recruiting | 2 | 92 | | losartan+Bevacizumab + chemotherapy (CapeOx+mXELIRI) | Jiangjin Central Hospital of Chongqing; Jiangjin Central Hospital of Chongqing, Scientific research fund | colorectal cancer | | | | |
| Withdrawn | 2 | 34 | Europe | Losartan, Gemcitabine, Nab paclitaxel, Stereotactic Body Radiation Therapy | Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori | Pancreatic Cancer | 12/24 | 12/24 | | |
NCT01199978: Hearing Outcomes Using Fractionated Proton Radiation Therapy for Vestibular Schwannoma |
|
|
| Active, not recruiting | 2 | 30 | US | Fractionated proton radiation, Losartan, Cozaar | Massachusetts General Hospital, National Cancer Institute (NCI) | Vestibular Schwannoma, Acoustic Neuroma | 11/26 | 11/26 | | |
IPAT, NCT05331144: Impact of Intensive Treatment of SBP on Brain Perfusion, Amyloid, and Tau ( Study) |
|
|
| Recruiting | 2 | 180 | US | Angiotensin II Receptor Blockers (ARBs, losartan) and Calcium Channel Blockers (CCB, amlodipine), PCP | Rong Zhang, National Institute on Aging (NIA), Texas Health Resources, Michigan State University | Cognitively Normal Older Adults, Hypertension, Subjective Cognitive Decline, Family History of Dementia | 06/27 | 12/27 | | |
NCT05637216: Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients |
|
|
| Recruiting | 2 | 40 | NA | Losartan 25 milligram capsule, losartan potassium, Placebo | Shaw Cancer Center, Steadman Philippon Research Institute | Radiation Induced Fibrosis | 08/27 | 08/27 | | |
NCT02263729: Phase 1/2 Prospective Double-Blind Placebo-Controlled Randomized Clinical Trial of Losartan to Treat Grade II & III Hamstring Strains |
|
|
| Terminated | 1/2 | 8 | US | Losartan, Placebo | James J. Irrgang, Brooke Army Medical Center, Wake Forest University | Hamstring Injury | 12/22 | 12/22 | | |
| Recruiting | 1/2 | 60 | US | Polypill, (Finerenone, Empagliflozin, Losartan) | University of Texas Southwestern Medical Center | Type 2 Diabetes, High Blood Pressure | 09/25 | 12/25 | | |
NCT05893108: Ethosomal Gel Bearing Losartan 5% for Keloid Treatment |
|
|
| Not yet recruiting | 1/2 | 46 | RoW | Ethosomal gel bearing losartan 5%, triamcinolone acetonide 10 mg/ml, TA 10 mg/ml | Yuni Eka Anggraini, Gadjah Mada University | Keloid | 09/24 | 10/24 | | |
NCT05025956: Senolytic Agent Improve the Benefit of Platelet-Rich Plasma and Losartan |
|
|
| Active, not recruiting | 1/2 | 68 | US | Fisetin, Novusetin, 7,3',4'-flavon-3-ol, 3,3',4',7-tetrahydroxyflavone, Placebo, Placebo Oral Capsule | Steadman Philippon Research Institute, United States Department of Defense | Femoroacetabular Impingement | 10/24 | 10/24 | | |
RMIP, NCT04815902: Use of Senolytic and Anti-Fibrotic Agents to Improve the Beneficial Effect of Bone Marrow Stem Cells for Osteoarthritis |
|
|
| Active, not recruiting | 1/2 | 100 | US | Fisetin, Novusetin, 7,3',4'-flavon-3-ol, 3,3',4',7-tetrahydroxyflavone, Losartan, Losartan potassium, Placebo - Losartan, Placebo Oral Capsule, Placebo Fisetin | Steadman Philippon Research Institute, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Osteoarthritis, Knee | 02/25 | 06/25 | | |
NCT06108063: Mitigation of Arthrofibrosis After Total Knee Arthroplasty Using Losartan |
|
|
| Recruiting | 1/2 | 120 | US | Losartan, Losartan potassium, Placebo - Losartan, Placebo Oral Tablet | Steadman Philippon Research Institute | Knee Arthroplasty, Total | 06/27 | 06/27 | | |
ACTRN12620000731998p: Will treating the overwhelming patient response with medications affect COVID-19 mortality? |
|
|
| Not yet recruiting | 1 | 36 | | | NSW Health via the Hunter New England Local Health District | COVID-19 | | | | |
ACTRN12620000731998: Will treating the overwhelming patient response with medications affect COVID-19 mortality? |
|
|
| Not yet recruiting | 1 | 36 | | | NSW Health via the Hunter New England Local Health District | COVID-19 | | | | |
| Completed | 1 | 720 | | losartan 50mg, orally taken once daily for 12 week ;Allisartan 240mg, orally taken once daily for 12 weeks | Peking University People's Hospital; Shanghai Allist Pharmaceuticals, Inc., Shanghai Allist Pharmaceuticals, Inc. | Mild to moderate essential hypertension | | | | |
ChiCTR-TRC-10001518: Helping Ease Renal Failure with Bupiyishen (HERB) Trial: A Randomised Controlled Trial of Bupi Yishen for slowing kidney failure progression in stage 4 chronic kidney disease |
|
|
| Completed | 1 | 550 | | BU PI YI SHEN Formula+placebo of Losartan+basal treatment ;Lorsartan+placebo of BU PI YI SHEN Formula+basal treatment | Guangdong Provicial Hospital of Chinese Medicine; State Bureau of Quality Technical Supervision of China, State Bureau of Quality Technical Supervision of China | chronic kidney disease 4th stage | | | | |
| Not yet recruiting | 1 | 16 | | phase I: Allisartan; phase II: Losartan ;phase I: Losartan; phase II: Allisartan. | The Third Xiangya Hospital of Central South University; Shenzhen Salubris Pharmaceuticals Co., Ltd., Sponsor | Hypertension | | | | |